Glimpses at the recognition of peptide/MHC complexes by T-cell antigen receptors. 1998

G Mazza, and D Housset, and C Piras, and C Gregoire, and S Y Lin, and J C Fontecilla-Camps, and B Malissen
Centre d'Immunologie INSERM-CNRS de Marseille-Luminy, France.

More than a decade after the first description of the primary structure of a T-cell antigen receptor (TCR), the recent determination of the crystal structure of several unliganded TCR ectodomains and of two TCRs complexed to peptide-MHC ligand provides a structural basis for understanding the initial event that triggers T-cell activation. This review focuses on the topology of the variable (V) domains found in TCRs and immunoglobulins and attempts to delineate the structural features that may render the TCR complementarity-determining regions particularly suited to dock on the peptide/MHC surface. Finally, the available TCR structures provide an opportunity to re-evaluate the molecular basis for intrathymic positive selection as well as the mechanisms that make a given TCR neither infinitely specific, nor so flexible that it engages productively any MHC-binding peptides.

UI MeSH Term Description Entries
D007135 Immunoglobulin Variable Region That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. Variable Region, Ig,Variable Region, Immunoglobulin,Framework Region, Immunoglobulin,Fv Antibody Fragments,Fv Fragments,Ig Framework Region,Ig Variable Region,Immunoglobulin Framework Region,Immunoglobulin Fv Fragments,Immunoglobulin V,Antibody Fragment, Fv,Antibody Fragments, Fv,Fragment, Fv,Fragment, Fv Antibody,Fragment, Immunoglobulin Fv,Fragments, Fv,Fragments, Fv Antibody,Fragments, Immunoglobulin Fv,Framework Region, Ig,Framework Regions, Ig,Framework Regions, Immunoglobulin,Fv Antibody Fragment,Fv Fragment,Fv Fragment, Immunoglobulin,Fv Fragments, Immunoglobulin,Ig Framework Regions,Ig Variable Regions,Immunoglobulin Framework Regions,Immunoglobulin Fv Fragment,Immunoglobulin Variable Regions,Regions, Immunoglobulin Variable,Variable Regions, Ig,Variable Regions, Immunoglobulin
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D006649 Histocompatibility Antigens A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection. Transplantation Antigens,Antigens, Transplantation,Histocompatibility Antigen,LD Antigens,SD Antigens,Antigen, Histocompatibility,Antigens, Histocompatibility,Antigens, LD,Antigens, SD
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

G Mazza, and D Housset, and C Piras, and C Gregoire, and S Y Lin, and J C Fontecilla-Camps, and B Malissen
November 2007, Trends in biochemical sciences,
G Mazza, and D Housset, and C Piras, and C Gregoire, and S Y Lin, and J C Fontecilla-Camps, and B Malissen
June 1998, Cellular immunology,
G Mazza, and D Housset, and C Piras, and C Gregoire, and S Y Lin, and J C Fontecilla-Camps, and B Malissen
December 2009, Current opinion in immunology,
G Mazza, and D Housset, and C Piras, and C Gregoire, and S Y Lin, and J C Fontecilla-Camps, and B Malissen
December 1993, Immunology today,
G Mazza, and D Housset, and C Piras, and C Gregoire, and S Y Lin, and J C Fontecilla-Camps, and B Malissen
January 2011, Molecular immunology,
G Mazza, and D Housset, and C Piras, and C Gregoire, and S Y Lin, and J C Fontecilla-Camps, and B Malissen
May 1995, Nature,
G Mazza, and D Housset, and C Piras, and C Gregoire, and S Y Lin, and J C Fontecilla-Camps, and B Malissen
February 2010, Immunity,
G Mazza, and D Housset, and C Piras, and C Gregoire, and S Y Lin, and J C Fontecilla-Camps, and B Malissen
December 1991, Science (New York, N.Y.),
G Mazza, and D Housset, and C Piras, and C Gregoire, and S Y Lin, and J C Fontecilla-Camps, and B Malissen
January 1989, Cold Spring Harbor symposia on quantitative biology,
G Mazza, and D Housset, and C Piras, and C Gregoire, and S Y Lin, and J C Fontecilla-Camps, and B Malissen
April 1992, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!